Q3 2024 EPS Estimates for Huron Consulting Group Inc. Lifted by Analyst (NASDAQ:HURN)

Huron Consulting Group Inc. (NASDAQ:HURN) – Investment analysts at William Blair raised their Q3 2024 EPS estimates for shares of Huron Consulting Group in a research report issued to clients and investors on Wednesday, July 31st. William Blair analyst A. Nicholas now forecasts that the business services provider will earn $1.70 per share for the quarter, up from their prior forecast of $1.68. The consensus estimate for Huron Consulting Group’s current full-year earnings is $5.94 per share. William Blair also issued estimates for Huron Consulting Group’s Q4 2024 earnings at $1.47 EPS, FY2024 earnings at $6.06 EPS and FY2025 earnings at $6.97 EPS.

Huron Consulting Group (NASDAQ:HURN) last issued its quarterly earnings data on Tuesday, July 30th. The business services provider reported $1.68 EPS for the quarter, beating analysts’ consensus estimates of $1.48 by $0.20. The firm had revenue of $371.70 million for the quarter, compared to analysts’ expectations of $374.33 million. Huron Consulting Group had a net margin of 5.46% and a return on equity of 20.19%. The firm’s revenue was up 7.2% on a year-over-year basis. During the same period in the prior year, the company earned $1.38 EPS.

Several other research analysts have also weighed in on HURN. Barrington Research reiterated an “outperform” rating and set a $133.00 price objective on shares of Huron Consulting Group in a report on Tuesday, May 28th. Benchmark reaffirmed a “buy” rating and issued a $140.00 price objective on shares of Huron Consulting Group in a research report on Wednesday. Truist Financial reaffirmed a “buy” rating and issued a $140.00 price objective on shares of Huron Consulting Group in a research report on Thursday, May 16th. Wedbush reaffirmed an “outperform” rating and issued a $110.00 price objective on shares of Huron Consulting Group in a research report on Thursday, May 23rd. Finally, StockNews.com raised shares of Huron Consulting Group from a “sell” rating to a “hold” rating in a research report on Saturday. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $130.75.

Huron Consulting Group Price Performance

NASDAQ:HURN opened at $108.51 on Thursday. The firm has a market cap of $1.93 billion, a price-to-earnings ratio of 31.27 and a beta of 0.61. The company has a current ratio of 2.40, a quick ratio of 2.40 and a debt-to-equity ratio of 1.13. The company’s 50-day moving average is $99.39 and its two-hundred day moving average is $97.70. Huron Consulting Group has a 12-month low of $84.26 and a 12-month high of $115.65.

Insider Transactions at Huron Consulting Group

In other news, Director John Mccartney sold 1,259 shares of the firm’s stock in a transaction that occurred on Tuesday, June 11th. The shares were sold at an average price of $95.38, for a total transaction of $120,083.42. Following the completion of the sale, the director now owns 57,988 shares of the company’s stock, valued at $5,530,895.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, CEO C. Mark Hussey sold 34,013 shares of Huron Consulting Group stock in a transaction dated Friday, July 12th. The shares were sold at an average price of $100.69, for a total transaction of $3,424,768.97. Following the sale, the chief executive officer now directly owns 85,081 shares in the company, valued at $8,566,805.89. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director John Mccartney sold 1,259 shares of Huron Consulting Group stock in a transaction dated Tuesday, June 11th. The shares were sold at an average price of $95.38, for a total transaction of $120,083.42. Following the sale, the director now owns 57,988 shares in the company, valued at $5,530,895.44. The disclosure for this sale can be found here. Over the last quarter, insiders sold 35,872 shares of company stock valued at $3,601,300. 2.02% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Semanteon Capital Management LP purchased a new position in Huron Consulting Group in the 4th quarter worth about $1,166,000. Wakefield Asset Management LLLP purchased a new position in Huron Consulting Group during the 1st quarter valued at about $921,000. Norges Bank purchased a new position in Huron Consulting Group during the 4th quarter valued at about $14,460,000. BNP Paribas Financial Markets grew its stake in Huron Consulting Group by 116.8% during the 4th quarter. BNP Paribas Financial Markets now owns 49,589 shares of the business services provider’s stock valued at $5,098,000 after acquiring an additional 26,714 shares in the last quarter. Finally, Vanguard Group Inc. grew its stake in Huron Consulting Group by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 2,073,879 shares of the business services provider’s stock valued at $200,378,000 after acquiring an additional 25,905 shares in the last quarter. 93.90% of the stock is owned by institutional investors and hedge funds.

Huron Consulting Group Company Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.